Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

January 31, 2006

Primary Completion Date

January 31, 2007

Study Completion Date

June 30, 2010

Conditions
Colorectal Cancer
Interventions
DRUG

SN-38 liposome

38 mg/sq m IV infusion over 30 min q 21 days (1 cycle) until progression

Trial Locations (10)

19713

CCOP - Christiana Care Health Services, Newark

19958

Tunnell Cancer Center at Beebe Medical Center, Lewes

21921

Union Hospital Cancer Program at Union Hospital, Elkton MD

28501

Kinston Medical Specialists, Kinston

89102

University Medical Center of Southern Nevada, Las Vegas

89106

CCOP - Nevada Cancer Research Foundation, Las Vegas

92120

Kaiser Permanente Medical Office -Vandever Medical Office, San Diego

08043

Cancer Institute of New Jersey at Cooper - Voorhees, Voorhees Township

27599-7295

Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill, Chapel Hill

43210-1240

Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center, Columbus

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Alliance for Clinical Trials in Oncology

OTHER

NCT00311610 - Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter